This CEO is Using LSD To Fight Depression, PMS, and Other Mental Health Conditions – Justin Hanka CEO -Co-Founder Of Mind Bio Therapeutics -CSE-$MBIO

This CEO is Using LSD To Fight Depression, PMS, and Other Mental Health Conditions – Justin Hanka CEO -Co-Founder Of Mind Bio Therapeutics -CSE-MBIO This CEO is Using LSD To Fight Depression, PMS, and Other Mental Health Conditions – Justin Hanka CEO -Co-Founder Of Mind Bio Therapeutics -CSE-MBIO Justin Hanka | Co-founder | Chief Executive Director MindBio Therapeutics Ltd Ticker: $MBIO – Canada. Frankfurt Börse - FRA: WF6 Website: https://www.mindbiotherapeutics.com/ Bio: Justin works in investment banking and financing of mergers and acquisitions and particularly he specializes in capital markets transactions and working with technology in the life and health sciences sector. He is Non-Executive Director of EonX (CSE:EONX), a financial technology company, Non-Executive Chairman of Blackhawk Growth Corp (CSE:BLR), an investment issuer and Non-Executive Director and Chairman of SPARC AI (CSE:SPAI), an engineering company commercializing covert geospatial location and tracking technology for drones. Justin is Co-Founder and CEO of Hardenbrook Group, a merchant and investment bank and Co-founder and CEO of MindBio Therapeutics (CSE:MBIO), a clinical stage pharma developing psychedelic microdosing formulations to treat depression and is currently dosing in multiple Phase 2B clinical trials. Justin is also Co-founder of Life AI Corp, a life sciences technology company developing AI solutions for longevity and enhancing health and wellness at scale. Justin’s expertise and interests span the pharmaceutical and life sciences sector, fin-techs, technology that utilizes AI and machine learning methods, banking and insurance, health and wellness, biohacking, anti-ageing and ecommerce.